Organigram (TSE:OGI) Stock Falls 3.6% – What’s Next?

Organigram Holdings Inc. (TSE:OGI) was down 3.6% during trading on Tuesday. The company traded as low as C$1.28 and last traded at C$1.32. 122,204 shares traded hands during trading, a decline of 38% from the average daily volume of 197,245 shares. The stock had previously closed at C$1.37.

Organigram Stock Down 3.6%

The firm’s fifty day simple moving average is C$1.54 and its 200 day simple moving average is C$1.58. The company has a debt-to-equity ratio of 6.48, a quick ratio of 2.62 and a current ratio of 2.61. The stock has a market capitalization of C$190.28 million, a price-to-earnings ratio of 2.20, a P/E/G ratio of 0.42 and a beta of 1.64.

Organigram (TSE:OGI) last posted its quarterly earnings data on Tuesday, August 11th. The company reported C$0.77 earnings per share for the quarter. Organigram had a return on equity of 21.99% and a net margin of 28.02%. The company had revenue of C$105.78 million during the quarter. On average, sell-side analysts forecast that Organigram Holdings Inc. will post 0.16 earnings per share for the current year.

Organigram Company Profile

Organigram Global Inc is listed on the NASDAQ Global Select Market and TSX. The Company’s wholly owned subsidiary, Organigram Inc, is a licensed cultivator and processor. Through its acquisition of Sanity Group GmbH (‘Sanity Group’), Organigram participates in the German medical cannabis market and other emerging markets within Europe. Organigram is focused on producing high-quality cannabis for adult consumers, as well as extending the Company’s global footprint. Organigram has also developed and acquired a portfolio of cannabis brands, including Edison, Big Bag O’ Buds, SHRED, Monjour, Tremblant, Collective Project, Trailblazer, BOXHOT and DEBUNK.